Cellebrite DI Ltd. (CLBT)
NEUTRALFondamental
68
Prix
$11.50
Capitalisation boursière
$2.84B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilan & Liquidités
Chiffre d'affaires
$496M
12 derniers mois (au 31/03/2026)
Résultat net
$72M
12 derniers mois (au 31/03/2026)
Flux de trésorerie libre
$125M
Capitaux propres totaux
$538M
Passif total
$23M
Ratio de liquidité général
1.62
Couverture des intérêts
-
Dette/EBITDA
0.30
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$19.57
Prix actuel
$11.50
Marge de sécurité
+41.2%
Fourchette de juste valeur
$12.72 - $26.42
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
49.22
ROE
12.4%
Ratio P/B
5.27
P/FCF
22.72
Marge brute
83.0%
ROIC
3.8%
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
3.8%
WACC
10.6%
ROIC − WACC
-6.7 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Critères d'analyse fondamentale
Réussi (13)
- Gross Margin 83.0%
- P/FCF 22.72
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 15.5%
- Revenue Growth 5Y 19.5%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 6.8%
- PEG Ratio 0.63
- Earnings Quality (OCF/NI) 2.01
- Net Margin Trend 16.5% vs -70.5%
Échoué (6)
- Price CAGR 0.81%
- ROIC 3.8%
- P/B Ratio 5.27
- CapEx intensity
- DCF valuation (Overvalued)
- Piotroski F-Score 2/9
Indisponible (8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Score F de Piotroski
Préoccupations financières sérieuses
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Gouvernance
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for CLBT, sourced from Markets Gazette.